KVPR got a grant from the Corp for Public Broadcasting to build an emergency auxiliary transmitter site as a backup to its ...
A key regulatory committee sided against the drug this summer. But an appeal from Eisai appears to have worked, teeing Leqembi up for authorization in a major market.
After re-examining its initial opinion, EMA’s human medicines committee, or CHMP, has recommended granting a marketing authorisation to Leqembi for treating mild cognitive impairment or mild dementia ...
FEMA fires worker for directing aid away from Trump supporters, sparking investigation and political backlash.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback
